Ad
related to: vertex
Search results
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should...
Zacks via Yahoo Finance· 1 day agoVertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Vertex stock target lifted, retains Outperform on pain management drug potential By Investing.com
Investing.com· 4 hours agoOn Friday, BMO Capital Markets adjusted its outlook on Vertex Pharmaceuticals (NASDAQ:VRTX)...
Insider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus.com via Yahoo Finance· 13 hours agoOn May 28, 2024, Charles F. Wagner Jr., Executive Vice President and Chief Financial Officer of ...
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Motley Fool via Yahoo Finance· 1 day agoIt's not from another medical device make -- it's from an innovative biotech company. Should Abbott...
Why Vertex Pharmaceuticals (VRTX) is a Top Growth Stock for the Long-Term
Zacks via Yahoo Finance· 1 day agoThis Score examines things like projected and historical earnings, sales, and cash flow to find...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 7 hours agoMeanwhile, the pharma group ranks No. 139. But it's key to watch specific measures when examining...
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
The Motley Fool via AOL· 5 days agoVertex Pharmaceuticals (NASDAQ: VRTX) is a fast-growing pharmaceutical company that investors have been bullish on for years. The business generates...
Vertex Pharmaceuticals (VRTX) – Analysts’ Weekly Ratings Changes
ETF DAILY NEWS· 3 days ago5/27/2024 – Vertex Pharmaceuticals was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating. 5/19/2024 – Vertex Pharmaceuticals ...
New Pain Drug Could Be Big For Vertex Stock As Shares Score Breakout
Investor's Business Daily· 7 days agoCystic fibrosis treatment leader Vertex Pharmaceuticals scored a breakout from a cup base the past...
Unveiling Vertex Pharmaceuticals (VRTX)'s Value: Is It Really Pr
Guru Focus· 3 days agoVertex Pharmaceuticals Inc (VRTX, Financial) recently noted a daily loss of 2.23%, yet it maintains a 3-month gain of 4.7%. This article delves into the valuation analysis ...